Republic Act No. 9502, otherwise known as the “Universally Accessible Cheaper and Quality Medicines Act of 2008,” mandated the Secretary of Health (SOH)to establish and initiate an electronic price monitoring and regulation system for drugs and medicines which is now known as the Electronic Drug Price Monitoring System (EDPMS).
Click the title to read more about the advisory.
The department of health have adjusted the price of several medicines under Government-Mediated Access Price (GMAP). To know more regarding the changes you can access the full contents here.
The Department of Health (DOH) informed the Bureau of Internal Revenue (BIR) through Commissioner Caesar R. Dulay the revisions to the list of VAT-Exempt Medicines under Republic Act. 11354 or Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.
The DOH Pharmaceutical Division expresses its gratitude to the leadership and concern for poor and vulnerable Filipino patients shown by President Rodrigo Duterte with the passage of two landmark Executive Orders which set maximum retail price to 120 high cost medicines.
The Food and Drug Administration (FDA) endorses to the Bureau of Internal Revenue (BIR) the updated list of VAT-Exempt Medicines (as of March 2022) under RA 11354, otherwise known as the Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act.
The Department of Health expressed elation over the signing of Executive Order (EO) No. 155, by President Rodrigo Roa Duterte adding 34 medicines to the list of drugs with mandatory price caps.
DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155
Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations Related Posts Maximum Retail Price of Drugs and Medicines 14 Sep 2020 (Executive Order #155) Further Improving Access to Healthcare continue reading : (Department Circular No. 2022-0046) Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav and Dutasteride Preparations
Generic Nomenclature of Amlodipine + Perindopril Products Under Executive Order No. 155 Related Posts Maximum Retail Price of Drugs and Medicines 14 Sep 2020 (Executive Order #155) Further Improving Access continue reading : (Department Circular No. 2022-0016) Generic Nomenclature of Amlodipine + Perindopril Products Under Executive Order No. 155
Department Circular 2021-0088 Related Posts Mark-up Regulation of Essential Medicines in DOH Facilities 07 Oct 2020 Drug Price Reference Index 07 Oct 2020 Maximum Retail Price of Drugs and Medicines continue reading : Government-Mediated Access Price (GMAP) Adjustment of Co-Amoxiclav Preparations